文献速递关节外科

全关节置换术患者接受阿司匹林与华法林后持续性伤口引流液的情况

Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin.
PubMed 文献 · J Arthroplasty · 2020-07-09

该回顾性研究纳入5516例初次全髋和全膝关节置换术患者,比较接受阿司匹林(ASA)或华法林(Coumadin)进行术后静脉血栓栓塞(VTE)预防的患者持续性伤口引流(PWD)的发生率。ASA组PWD发生率低于华法林组(3.2% vs 8.5%,P < .0001),而30天VTE和6个月假体周围感染(PJI)发生率两组相当。华法林是PWD的独立危险因素(OR 1.7,95%CI 1.2-2.2)。

要点

  • ASA组PWD发生率3.2%,低于华法林组的8.5%(P < .0001)。
  • 两组30天VTE(1.3% vs 1.4%,P = .722)和6个月PJI(1.8% vs 1.4%,P = .233)无显著差异。
  • 华法林是PWD的独立危险因素(OR 1.7,95%CI 1.2-2.2)。

核心结论

  • 与华法林相比,使用ASA与THA和TKA术后PWD发生率显著降低相关,同时预防VTE的疗效相当。
  • 华法林被确定为PWD的独立危险因素。

研究设计与样本

  • 回顾性综述,纳入5516例初次全髋和全膝关节置换术患者。
  • 采用卡方检验比较ASA组与华法林组PWD、30天VTE和6个月PJI的发生率,采用多因素回归模型(使用Charlson和Elixhauser合并症指数)识别PWD的独立危险因素。

主要发现

  • PWD的总体发生率为6.4%(353/5516)。
  • 接受ASA的患者PWD发生率低于接受华法林的患者(3.2% vs 8.5%,P < .0001)。
  • ASA组与华法林组30天VTE发生率分别为1.3%和1.4%(P = .722),6个月PJI发生率分别为1.8%和1.4%(P = .233),两组间无显著差异。
  • PWD的危险因素包括:糖尿病(OR 19.3;95%CI 11.8-23.2)、类风湿关节炎(OR 15.3;95%CI 10.8-17.2)、病态肥胖(OR 13.2;95%CI 9.7-17.5)、慢性酒精使用(OR 3.5;95%CI 1.8-5.5)、甲状腺功能减退(OR 1.9;95%CI 1.1-3.2)以及华法林(OR 1.7;95%CI 1.2-2.2)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent wound drainage (PWD) is one of the major risk factors for periprosthetic joint infections (PJI), arguably the most dreaded complications after a total hip and knee arthroplasty (THA and TKA). The aim of this study is to identify the rates of PWD among THA and TKA patients who received aspirin (ASA) or Coumadin for postoperative venous thromboembolism (VTE) prophylaxis. METHODS: Retrospective review of 5516 primary THA and TKA was performed. Patients with PWD were identified. Chi-square test was used to compare the incidences of PWD, 30-day VTE, and PJI at 6 months between the ASA and Coumadin groups. Multivariate regression model was used to identify independent risk factors for PWD using Charlson and Elixhauser comorbidity indexes. RESULTS: The prevalence of PWD was 6.4% (353/5516). Patients receiving ASA had lower incidence of PWD (3.2% vs 8.5%, P < .0001) while having comparable rates of 30-day VTE (1.3% vs 1.4%, P = .722) and PJI at 6 months (1.8% vs 1.4%, P = .233) compared to those receiving Coumadin. Risk factors for PWD were diabetes (odds ratio [OR], 19.3; 95% confidence interval [CI], 11.8-23.2), rheumatoid arthritis (OR, 15.3; 95% CI, 10.8-17.2), morbid obesity (OR, 13.2; 95% CI, 9.7-17.5), chronic alcohol use (OR, 3.5; 95% CI, 1.8-5.5), hypothyroidism (OR, 1.9; 95% CI, 1.1-3.2), and Coumadin (OR, 1.7; 95% CI, 1.2-2.2). CONCLUSION: Use of ASA is associated with significantly lower rates of PWD after THA and TKA when compared to Coumadin while being equally efficacious at preventing VTE. Coumadin was found to be an independent risk factor for PWD.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Singh V, Shahi A, Saleh U, et al. Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin. J Arthroplasty. 2020. PMID: 32788061. doi:10.1016/j.arth.2020.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。